Research

Previously funded studies appear chronologically, with the most recent appearing first.

  • Assessing How a Protein Helps Hemangiosarcoma Cells Survive

    2013
    Canine hemangiosarcoma is a common and highly fatal cancer in dogs. Recent evidence suggests that populations of cancer stem cells give rise to tumors, promote tumor growth and are the main culprits behind drug resistance and disease recurrence. This study examines how a protein expressed by stem cells contributes to the maintenance and survival of […]
    Continue reading

  • Determining a More Effective Treatment for Canine Lymphoma

    2013
    This study evaluates the efficacy of two antibodies that could treat canine B-cell lymphoma. The investigators theorize that either antibody alone will kill lymphoma cells and delay tumor progression but that the combined effect of the two antibodies will be more effective as a treatment for dogs with lymphoma. Co-sponsored with the Morris Animal Foundation, […]
    Continue reading

  • Evaluating a Novel Drug for Lymphoma

    2013
    Lymphoma accounts for an estimated 25 percent of all canine cancers. This study investigates a new therapeutic antibody that appears to effectively kill canine lymphoma cells but does not appear to result in serious side effects. Researchers will work to find the best dosage and evaluate the drug’s safety and effectiveness in dogs with B-cell […]
    Continue reading

  • Searching for Ways to Control Hemangiosarcoma Cancer Cells in Dogs

    2013
    Hemangiosarcoma is a highly metastatic and incurable cancer that can affect dogs at any age. It is particularly prevalent in certain breeds such as Golden Retrievers, German Shepherds and Portuguese Water Dogs. Unfortunately, hemangiosarcoma is a disease that is poorly understood and for which there are currently no good treatment options. One of the main […]
    Continue reading

  • Plasma Cortisol Concentration in Dogs with Pituitary Dependent Hyperadrenocorticism and Atypical Cushing’s Syndrome

    2012
    To use a modified version of intermittent samplings to assess whether dogs with atypical Cushing’s syndrome produce increased cortisol over a certain time period. Results Twenty-eight dogs were enrolled in the study to compare cortisol concentrations among healthy dogs, dogs with excess cortisol associated with pituitary dependent Cushing’s syndrome and dogs categorized as having “atypical” […]
    Continue reading

  • Genetic Background and the Angiogenic Phenotype in Cancer

    2012
    This project will continue the researchers’ observations on gene appearance profiles in hemangiosarcoma from Golden Retrievers to German Shepherd Dogs and Portuguese Water Dogs, and it also will define how new targeted therapies may effectively control the disease in these and other dog breeds. Results Certain dog breeds are prone to develop certain types of […]
    Continue reading

  • Understanding the Role of Specific Cells in Spreading Lymphoma

    2012
    One of the limitations in identifying therapeutic targets for canine lymphoma has been the lack of reliable systems to study lymphoma cells in the laboratory. This study uses a culture system, developed by the principal investigator, to maintain lymphoma cells in the laboratory and study a protein that helps lymphoma spread. The findings may highlight […]
    Continue reading

  • Developing a New Treatment for Canine Lymphoma

    2012
    To develop a drug similar to Rituximab that works on canine lymphoma patients. Blood cell lymphomas affect about 30 dogs in every 100,000. Diffuse large B cell lymphoma (DLBCL) is a common type affecting dogs and is similar to non-Hodgkin’s lymphoma in humans. Current treatment induces remission in about 75 percent of patients but the […]
    Continue reading

  • Determining the Correct Dosing for a Novel Drug to Treat Canine Lymphoma

    2011
    This study will determine the best dose for dogs with lymphoma, and researchers will study how well AD 198 affects cancer cells.
    Continue reading

  • Potential Drug Therapy for Lymphoma

    2011
    Lymphoma is one of the most common and fatal cancers in dogs. Most dogs treated with chemotherapy go into remission, but the cancer quickly develops drug resistance and recurs. Chemotherapy generally works by initiating apoptosis, a normal process in which cells undergo programmed death. Apoptosis occurs throughout life and is critical for developing and maintaining […]
    Continue reading